台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-光和 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw03/0803/1803/2804/2005/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0202/1202/249095100105110115120125May '24Jul '24Sep '24Nov '24Mar '2560d90dAll

光和 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/287102.867100.71100.5001,7520.00%
2025/03/276103.506104.25103.5001,7280.00%
2025/03/266104.506105.00104.5001,7230.00%
2025/03/256105.8300.00104.5061,7190.35%
2025/03/210.1107.0000.00106.500.11,7140.00%
2025/03/1400.001105.50105.00-11,713-0.06%
2025/03/136106.8300.00103.5061,7070.35%
2025/03/113106.5000.00107.0031,6970.18%
2025/03/100.1105.5000.00107.000.11,6860.00%
2025/03/063114.172111.00111.0011,6470.06%
2025/03/0500.002115.50115.50-21,645-0.12%
2025/03/032113.2500.00112.5021,6200.12%
2025/02/272112.502109.00109.0001,5680.00%
2025/02/263117.503117.67115.5001,5530.00%
2025/02/251112.502113.00113.00-11,443-0.07%
2025/02/244114.251115.00115.0031,4310.21%
2025/02/211113.001113.50113.0001,4120.00%
2025/02/2000.006110.00110.00-61,389-0.43%
2025/02/182110.5000.00110.0021,4010.14%
2025/02/131111.5000.00111.5011,4130.07%
2025/02/111111.0000.00109.0011,3920.07%
2025/02/101119.0000.00118.5011,3370.07%
2025/02/0700.001119.50120.50-11,351-0.07%
2025/02/061123.000.1119.00119.000.91,3290.07%
2025/02/0500.003113.00113.00-31,194-0.25%
2025/01/15293.5000.0093.1021,3800.14%
2025/01/09196.2000.0094.6011,3410.07%
2025/01/0600.001100.50101.50-11,259-0.08%
2025/01/03197.2000.0098.3011,2400.08%
2025/01/0200.00295.8093.60-21,235-0.16%
2024/12/30292.1000.0091.0021,2240.16%
2024/12/2700.001992.3492.00-191,223-1.55%
2024/12/2600.00593.1492.50-51,225-0.41%
2024/12/2500.00390.9391.00-31,214-0.25%
2024/12/17386.1000.0086.7031,2230.25%
2024/12/16387.4000.0086.3031,2160.25%
2024/12/13389.2000.0088.8031,2090.25%
2024/12/12790.7900.0090.2071,1990.58%
2024/12/11291.6000.0090.6021,1930.17%
2024/12/10292.6000.0092.1021,1880.17%
2024/12/09292.5000.0092.5021,1840.17%
2024/12/06293.4000.0093.3021,1800.17%
2024/12/03295.1000.0094.4021,1610.17%
2024/12/02195.3000.0094.4011,1580.09%
2024/11/2900.00197.5097.50-11,136-0.09%
2024/11/26194.2000.0094.0011,0840.09%
2024/11/1800.00298.3096.50-21,010-0.20%
2024/11/1500.001100.5099.90-1989-0.10%
2024/11/1300.000.1106.00106.50-0.1946-0.01%
2024/11/1200.000.4101.50104.00-0.4916-0.04%
2024/11/0500.002107.00106.00-2782-0.26%
2024/11/042102.0000.00100.0027580.26%
2024/11/013107.173106.17105.0007300.00%
2024/10/2900.002100.00100.50-2604-0.33%
2024/10/282102.508102.63102.00-6576-1.04%
2024/10/24397.301098.7898.30-7494-1.42%
2024/10/23194.90493.5893.70-3424-0.71%
2024/10/0800.00393.9091.10-3507-0.59%
2024/09/2400.001188.8490.20-11612-1.79%
2024/09/201087.38187.8087.4096441.40%
2024/09/1900.00684.8886.00-6636-0.94%
2024/09/13282.15182.5082.2016440.16%
2024/09/1200.00182.6082.20-1651-0.15%
2024/09/1000.00283.0583.30-2662-0.30%
2024/09/09581.92181.8082.0046660.60%
2024/09/0600.00182.9083.00-1682-0.15%
2024/09/0500.00182.4082.10-1689-0.15%
2024/08/2900.00286.1086.30-2729-0.27%
2024/08/221.287.05187.7086.600.27400.03%
2024/08/21186.80187.3086.6007460.00%
2024/08/1500.00184.4084.50-1745-0.13%
2024/08/131.284.6400.0084.401.27720.15%
2024/08/1200.00184.3084.90-1780-0.13%
2024/08/09186.00286.3085.40-1783-0.13%
2024/08/08185.9000.0085.4017990.13%
2024/08/0700.00786.7386.70-7794-0.88%
2024/08/06476.60379.4380.8017830.13%
2024/08/05484.0000.0083.0047640.52%
2024/08/02292.10291.9092.2007410.00%
2024/08/01194.60195.0094.5007360.00%
2024/07/2600.00196.9097.60-1729-0.14%
2024/07/23194.2000.0094.5017200.14%
2024/07/22191.1000.0092.0017180.14%
2024/07/1800.00198.8099.40-1676-0.15%
2024/07/15198.70198.4098.4006630.00%
2024/07/10196.70196.9096.6006580.00%
2024/07/0500.00296.7097.50-2625-0.32%
2024/07/0100.00299.80101.00-2610-0.33%
2024/06/26197.20297.3097.60-1576-0.17%
2024/06/14195.40295.6095.30-1655-0.15%
2024/06/1100.00195.2095.40-1636-0.16%
2024/06/07192.303294.0794.50-31644-4.81%
2024/06/06791.3900.0091.1076301.11%
2024/06/0500.00493.0592.90-4632-0.63%
2024/06/04591.2400.0090.8056470.77%
2024/06/03490.7000.0090.7046930.58%
2024/05/30990.7000.0090.3097371.22%
2024/05/29291.6000.0091.5027470.27%
2024/05/28292.0000.0092.3027600.26%
2024/05/27691.7000.0091.7067760.77%
2024/05/24292.9000.0092.8028080.25%
2024/05/17096.2000.0097.9008720.00%
2024/05/1400.00795.8694.30-71,043-0.67%
2024/05/13392.4000.0092.6031,0380.29%
2024/05/07492.8000.0092.8041,1160.36%
2024/04/2900.001394.9095.30-131,430-0.91%
2024/04/19789.8300.0089.0071,5230.46%
2024/04/16492.1000.0091.0041,5570.26%
2024/04/15394.1000.0094.1031,5650.19%
2024/04/03198.40198.8099.0001,7770.00%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章